Fundraising Fox

Onc

3 known investors

Find your way into Onc

Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.

AI & Machine LearningBiotechDigital Health

Founders & leadership

ANAkshay Nanduri
Akshay NanduriinFounderExecutive Officer, Director at Reflexionmedical

Investors · 3

LifeX VenturesSan Franciscovia Inaki Berenguer · inferred
Digitalis VenturesreportedNew York · $100K – $10M
KdT VenturesreportedAustin · $500K – $3M

In the news

Immune-Onc Therapeutics Raises More Than $33M in Series B Fundingfinsmes.com · Sep 2018Immune-Onc raises $33M in Series B funding round for immunotherapy pipeline - MedCity Newsmedcitynews.com · Sep 2018

Frequently asked questions

What does Onc do?
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.
Who founded Onc?
Onc was founded by Akshay Nanduri.
Who are Onc's investors?
Onc's investors include LifeX Ventures, Digitalis Ventures, KdT Ventures.